Recombinant Human SUMO3 (C-6His)

Recombinant Human SUMO3 (C-6His)

Size1:10μg price1:$66
Size2:50μg price2:$186
Size3:500μg price3:$1240
SKU: PHH1542 Category: Target Proteins Tags: ,

Datasheet

Name

Recombinant Human SUMO3 (C-6His)

Purity

Greater than 95% as determined by reducing SDS-PAGE

Endotoxin level

<1 EU/µg as determined by LAL test.

Construction

Recombinant Human Small Ubiquitin-related Modifier 3 is produced by our Mammalian expression system and the target gene encoding Ser2-Gly92 is expressed with a 6His tag at the C-terminus.

Accession #

P55854

Host

Human Cells

Species

Human

Predicted Molecular Mass

11.1 KDa

Buffer

Lyophilized from a 0.2 μm filtered solution of 20 mM Citrate, 10% Trehalose, 3% Dextran-70, 50mM NaCl, 0.05% Tween80, pH3.5.

Form

Lyophilized

Shipping

The product is shipped at ambient temperature.Upon receipt, store it immediately at the temperature listed below.

Stability&Storage

Store at ≤-70°C, stable for 6 months after receipt.Store at ≤-70°C, stable for 3 months under sterile conditions after opening. Please minimize freeze-thaw cycles.

Reconstitution

Always centrifuge tubes before opening.Do not mix by vortex or pipetting.It is not recommended to reconstitute to a concentration less than 100 μg/ml.Dissolve the lyophilized protein in distilled water.Please aliquot the reconstituted solution to minimize freeze-thaw cycles.

 

 

 

Alternative Names

Small ubiquitin-related modifier 3; SUMO-3; SMT3 homolog 1; SUMO-2; Ubiquitin-like protein SMT3A; Smt3A

 

Background

Small ubiquitin-like modifier (SUMO), also known as SUMO homologue and SMT3, is a member of the superfamily of ubiquitin-like polypeptides that become covalently attached to various intracellular target proteins as a way to alter their function, location, and/or half-life. Small ubiquitin-like modifiers include SUMO1, SUMO2, SUMO3, and SUMO4. Except for SUMO4, all other SUMOs are ubiquitously expressed, including in the brain. In human, SUMO2 and SUMO3 are two highly homologous proteins, collectively called SUMO2/3. Several studies suggest that SUMO3 are associated with pathogenesis in several neurological diseases, including Alzheimers disease, Parkinsons disease, and cerebral ischemia/stroke.

 

Note

For Research Use Only , Not for Diagnostic Use.